Christopher J. Nardo
CIK: 0001870247
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DRMA
Dermata Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Nardo Christopher J.
Nardo Christopher J. (SEC CIK 0001870247) files insider reports with the SEC as Senior VP, CDO of Dermata Therapeutics, Inc. (DRMA).
Signal8 holds 2 ownership filings by Nardo Christopher J., all Form 4s, filed between Jan 14, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 13, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nardo Christopher J.'s filings is in SAN DIEGO, CA.
Recent filings by Nardo Christopher J.
Other insiders filing for Dermata Therapeutics, Inc. (DRMA)
- PROEHL GERALD T, PRESIDENT, CHAIRMAN, CEO
- Van Hoose Kyri K., SVP, CFO
- Scott Kathleen D., Director
- Bedoya-Toro Munera Maria E, SVP, Regulatory Affairs
- WIERENGA WENDELL, Director
- HALE DAVID F, Director